Cargando…
TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer
BACKGROUND: TRAF2 exerts important functions in regulating the development and progression of cancer. The aim of this study is to investigate whether TRAF2 is a valuable prognostic biomarker and to determine if it regulates TRAIL-induced apoptosis in prostate cancer. MATERIAL/METHODS: Microarray gen...
Autores principales: | Wei, Bingbing, Liang, Jiabei, Hu, Jimeng, Mi, Yuanyuan, Ruan, Jun, Zhang, Jian, Wang, Zhirong, Hu, Qiang, Jiang, Haowen, Ding, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590516/ https://www.ncbi.nlm.nih.gov/pubmed/28855498 http://dx.doi.org/10.12659/MSM.903500 |
Ejemplares similares
-
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer
por: Liang, Jiabei, et al.
Publicado: (2017) -
Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma
por: Zhang, Wenqing, et al.
Publicado: (2017) -
Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer
por: Niu, Wen-Bin, et al.
Publicado: (2014) -
MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells
por: Lv, Feng, et al.
Publicado: (2017) -
C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance
por: Meng, Jie, et al.
Publicado: (2017)